Dolby Laboratories (DLB) Current Deferred Revenue (2009 - 2026)

Dolby Laboratories (DLB) has reported Current Deferred Revenue for 18 consecutive years, with $33.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue fell 6.77% year-over-year to $33.6 million; the trailing twelve-month figure through Jun 2026 stood at $33.6 million (down 6.77% YoY), and the FY2025 full-year result was $31.4 million, down 0.83% from the prior year.
• Current Deferred Revenue retreated to $33.6 million in Q2 2026 per DLB's latest filing, from $38.8 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $39.6 million in Q1 2025 and bottomed at $18.6 million in Q3 2022.
• Historically, Current Deferred Revenue has averaged $31.4 million across 5 years, with a median of $33.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue surged 72.45% in 2023, then retreated 10.76% in 2024.
• Over 5 years, Current Deferred Revenue stood at $22.4 million in 2022, then surged by 49.42% to $33.4 million in 2023, then climbed by 11.1% to $37.1 million in 2024, then declined by 0.05% to $37.1 million in 2025, then retreated by 9.44% to $33.6 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $33.6 million, $38.8 million, and $37.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.